Date published: 2026-11-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

MRP1 Antibody (QCRL-3): sc-18873

4.0(4)
Write a reviewAsk a question
Datasheets
  • MRP1 Antibody (QCRL-3) is a mouse monoclonal IgG2a κ, cited in 5 publications, provided at 200 µg/ml
  • raised against membranes prepared from the human small cell lung cancer cell line, H69AR, which highly overexpresses MRP1
  • recommended for detection of MRP1 of human origin by IF and FCM
  • available conjugated to either phycoerythrin or FITC for IF, IHC(P) and FCM
  • See MRP1 (QCRL-1): sc-18835 for MRP1 antibody conjugates, including AC, HRP, FITC, PE, Alexa Fluor® 488, 594, 647, 680 and 790.
  • m-IgG Fc BP-HRP, m-IgG2a BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for MRP1 Antibody (QCRL-3). These reagents are now offered in bundles with MRP1 Antibody (QCRL-3) (see ordering information below).
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

MRP1 Antibody (QCRL-3) is a mouse monoclonal IgG2a antibody that detects MRP1 in human samples through immunofluorescence (IF) and flow cytometry (FCM) applications. MRP1, or multidrug-resistance protein 1, plays a crucial role in the cellular defense mechanism against toxic compounds, including chemotherapeutic agents, by actively transporting a variety of substrates out of cells. This function is particularly important in the context of cancer, where overexpression of MRP1 can lead to multidrug resistance, making MRP1 a significant target for therapeutic intervention. MRP1 is primarily localized in the plasma membrane of various cell types, including those in the lungs, testis, and peripheral blood, which underscores MRP1′s importance in protecting these tissues from harmful substances. MRP1′s structure features an Mdr-like core and a unique N-terminal membrane-bound region, which are essential for transport activity and substrate specificity. Understanding the localization and function of MRP1 is vital for developing strategies to overcome drug resistance in cancer therapy, making MRP1 monoclonal antibody (QCRL-3) an invaluable tool for researchers studying multidrug resistance mechanisms in human cells.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.

Download thiomersal SDS

MRP1 Antibody (QCRL-3) References:

  1. Potent interaction of flavopiridol with MRP1.  |  Hooijberg, JH., et al. 1999. Br J Cancer. 81: 269-76. PMID: 10496352
  2. Structural, mechanistic and clinical aspects of MRP1.  |  Hipfner, DR., et al. 1999. Biochim Biophys Acta. 1461: 359-76. PMID: 10581367
  3. Preparation of an antibody recognizing both human and rodent MRP1.  |  Fernetti, C., et al. 2001. Biochem Biophys Res Commun. 288: 1064-8. PMID: 11689020
  4. Localization of the GSH-dependent photolabelling site of an agosterol A analog on human MRP1.  |  Ren, XQ., et al. 2003. Br J Pharmacol. 138: 1553-61. PMID: 12721111
  5. Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody.  |  Binyamin, L., et al. 2004. Int J Cancer. 110: 882-90. PMID: 15170671
  6. Mrp1 localization and function in cardiac mitochondria after doxorubicin.  |  Jungsuwadee, P., et al. 2009. Mol Pharmacol. 75: 1117-26. PMID: 19233900
  7. Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma.  |  Cai, BL., et al. 2011. Oral Oncol. 47: 1134-40. PMID: 21903448
  8. Inhibition of the MRP1-mediated transport of the menadione-glutathione conjugate (thiodione) in HeLa cells as studied by SECM.  |  Koley, D. and Bard, AJ. 2012. Proc Natl Acad Sci U S A. 109: 11522-7. PMID: 22679290
  9. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer.  |  Li, F., et al. 2021. Int J Pharm. 604: 120760. PMID: 34077781
  10. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer.  |  Li, F., et al. 2022. Int J Pharm. 625: 122076. PMID: 35931394

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

MRP1 Antibody (QCRL-3)

sc-18873
200 µg/ml
$322.00

MRP1 Antibody (QCRL-3): m-IgG Fc BP-HRP Bundle

sc-536604
200 µg Ab; 10 µg BP
$361.00

MRP1 Antibody (QCRL-3): m-IgGκ BP-HRP Bundle

sc-533759
200 µg Ab; 40 µg BP
$361.00

MRP1 Antibody (QCRL-3): m-IgG2a BP-HRP Bundle

sc-547842
200 µg Ab; 10 µg BP
$361.00

MRP1 Antibody (QCRL-3) FITC

sc-18873 FITC
200 µg/ml
$336.00

MRP1 Antibody (QCRL-3) PE

sc-18873 PE
200 µg/ml
$349.00